TITLE: “De novo Metastatic Breast Cancer: Prognosis and Surgical Considerations” 

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Estimate survival outcomes for patients with de novo metastatic breast cancer (dnMBC). 

• Identify factors associated with survival outcomes for patients with dnMBC. 

• Interpret the current literature related to surgical resection of the primary tumor for patients with dnMBC. 

Relevant financial relationship(s) with ineligible companies: 

Steven Bowers - Intellectual Property - Suture Shield, LLC; Consulting – BK Medical; Stock - Suture Shield, LLC   

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies: 

Kara Robinson, Hannah Coverstone, and Austin Meyer 

Presenter: Jennifer Plichta, MD

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:  None.
 

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.